Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Slides:



Advertisements
Similar presentations
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà
Advertisements

Development of Patient-Centered Questionnaires FDA/Industry Workshop – Washington DC 2005 Cindy Rodenberg, Ph.D Procter & Gamble Pharmaceuticals.
Andrea M. Landis, PhD, RN UW LEAH
Individual Treatment Plan Putting Together the Pieces of the Puzzle Gayla Oakley RN, FAACVPR Boone County Health Center Albion Nebraska Presented by Mark.
General Information --- What is the purpose of the test? For what population is the designed? Is this population relevant to the people who will take your.
1Concepts of Physical Fitness 12e Presentation Package for Concepts of Physical Fitness 12e Section III: Concept 06 Learning Self-Planning Skills for Lifetime.
1 Epoetin Alpha: FDA Overview of Patient Reported Outcome (PRO) Claims Ann Marie Trentacosti, M.D. Study Endpoints and Labeling Office of New Drugs Food.
Gayla Oakley RN, FAACVPR Boone County Health Center Albion Nebraska
DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Writing a Research Protocol Michael Aronica MD Program Director Internal Medicine-Pediatrics.
Chapter 13: Descriptive and Exploratory Research
Transcultural Research Prof. N.J.Mathers Institute of primary and community care University of Sheffield.UK 06/Nov/2007.
Sampling and Data Collection
RESEARCH METHODS IN EDUCATIONAL PSYCHOLOGY
…patient reported outcome (PRO) measure for your clinical study Dr Keith Meadows, DHP Research & Consultancy Ltd.
Patient-reported outcome measures for sleep-wake function Daniel J. Buysse, M.D. Jean Miewald, B.A. University of Pittsburgh School of Medicine PMBC Sleep.
PROactive Physical Activity as a Crucial Patient Reported Outcome in COPD
From Evidence to EMS Practice: Building the National Model Eddy Lang, MD, CFPC (EM), CSPQ SMBD-Jewish General Hospital, McGill University Montreal, Canada.
Questionnaires & Opinionnaires Advantages Large volume of data gathered in a very short time. Ease of administration Consistent response Low cost.
Case study Title: To measure quality of life and social participation Specific theme: To measure quality of life and social participation among HI and.
Dr Keith Meadows, DHP Research & Consultancy Ltd.
Cognitive Interviewing for Question Evaluation Kristen Miller, Ph.D. National Center for Health Statistics
1 October, 2005 Activities and Activity Director Guidance Training (F248) §483.15(f)(l), and (F249) §483.15(f)(2)
Selection of a Survey Instrument for a Heart Failure Disease Management Study Lee R. Goldberg, MD, MPH Heart Failure/Transplant program University of Pennsylvania.
SPECA Regional Wrokshop on Disability Statistics, Dec 13-15, 2006 Issues Related to Disability Measurement: Cognitive testing and mode Jennifer Madans.
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Joseph Finkelstein, MD, PhD, MA, CCRP ICTR Clinical Registry Workshop, 10 November 2010.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
EVALUATION APPROACHES Heather Aquilina 24 March 2015.
The Practical Art of Endpoint Selection: Industry Perspectives A View from the Pharma Industry of the FDA Guidance on PROs Glenn A. Phillips, Ph.D. Director.
A checklist for evaluating the validity and suitability of existing physical activity and sedentary behavior instruments Maria Hagströmer, Karolinska Institutet,
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Evidence and Information for Policy Health as a multi-dimensional construct and cross-population comparability Colin Mathers (WHO) on behalf of Taskforce.
OLGA: A nice niche designed to meet your evolving needs Pennifer Erickson, Ph.D. Presented at the Spring meeting of the Special Library Association’s Pharmaceutical.
Regulatory Affairs and Adaptive Designs Greg Enas, PhD, RAC Director, Endocrinology/Metabolism US Regulatory Affairs Eli Lilly and Company.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Psychometric Evaluation of Questionnaire Design and Testing Workshop December , 10:00-11:30 am Wilshire Suite 710 DATA.
Chapter 14: Affective Assessment
Health Behavior Assessment
Chapter 9 – Assessment: Integration and Clinical Decision Making Copyright © 2014 John Wiley & Sons, Inc. All rights reserved.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Guidelines Recommandations. Role Ideal mediator for bridging between research findings and actual clinical practice Ideal tool for professionals, managers,
Considerations in Comparing Groups of People with PROs Ron D. Hays, Ph.D. UCLA Department of Medicine May 6, 2008, 3:45-5:00pm ISPOR, Toronto, Canada.
Principles of Assessment and Outcome Measurement for Physical Therapists ksu. edu. sa Dr. taher _ yahoo. com Mohammed TA, Omar,
Healthand Quality of Life BIOPSYCHOSOCIAL MODEL OF WELL-BEING.
Suzan F. Ayers and Mary Jo Sariscsany Introduction to Physical Best 1 chapter.
Program Planning for Evidence-based Health Programs.
PULMONARY REHABILITATION.
CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?
Quantification of dyspnea using descriptors: Development and initial testing of the Dyspnea-12 J Yorke, S H Moosavi, C Shuldham, P W Jones (Thorax
Instrument Development and Psychometric Evaluation: Scientific Standards May 2012 Dynamic Tools to Measure Health Outcomes from the Patient Perspective.
Introduction to Neuro-QoL
Patient-Reported Outcomes (PROs) Assessment
Patient Focused Drug Development An FDA Perspective
Development of PRO Content
Evidence-based Medicine
Qualitative research: an overview
Clinical Studies Continuum
Medical care and self-management support for asthma in primary care: a comparison between France and the United Kingdom A.Dima, E. van Ganse, H. Le Cloarec,
Introduction to Neuro-QoL
Technology Working Group Meeting
Introduction to Neuro-QoL
ابزار گرد آوری داده ها 1- پرسشنامه 2- مشاهده 3- مصاحبه
Physical Activity as a Crucial Patient Reported Outcome in COPD
Regulatory Perspective of the Use of EHRs in RCTs
Connecting Foster and Kinship Carers SA Morning Tea: Fetal Alcohol Spectrum Disorders Stewart McDougall.
Presentation transcript:

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà dell’autore e fornito come supporto didattico per uso personale.

Development and validation of new patient related outcomes Thierry Troosters

Outline What are patient reported outcomes – The researchers perspective – Regulators perspective PRO science: Validating new PRO’s The example of PROactive

Troosters Respir Medicine 2010 Watz AJRCCM 2008 PROs and other outcomes LF COPD Exacer- bation Genes Smoking Noxious gases Symptoms reduced activity de-conditioning skeletal muscle dysfunction & Comorbidity increased breathing requirements Pathology What the disease means to the patient

LF COPD Exacer- bation Genes Smoking Noxious gases Symptoms reduced activity de-conditioning skeletal muscle dysfunction & Comorbidity increased breathing requirements Pathology What the disease means to the patient Classical outcomes Lung function CT-scan (Bio-markers) Classical outcomes Exercise capacity Patient Reported Outcomes Few are available PROs and other outcomes

PRO: definition A report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else. FDA guidance document

PROs: Insight in effect Patient reported outcome tools may help capturing events that happen outside a ‘clinical contact’ (e.g. Exacerbations, side effects)

PROs: Insight in effect Patient reported outcome tools may help capturing events that happen outside a ‘clinical contact’ (e.g. Exacerbations) Day Mean Daily EXACT total scores Leidy AJRCCM 2011 EXACT PRO Frequency and severity of exacerbations

PROs: Insight in effect Patient reported outcome tools may help capturing events that happen outside a ‘clinical contact’ Some (side-) effects of interventions are only known to the patient Aquadro Value Health 2003

PROs: Insight in effect Patient reported outcome tools may help capturing events that happen outside a ‘clinical contact’ Some (side-) effects of interventions are only known to the patient Aquadro Value Health 2003 PROs often integrate several ‘physiologic’ effects of interventions

PROs: Insight in effect CRDQ vs QF R=0.17 CRDQ vs 6MWDR=0.27

1.71 ± 0.24 points.yr ± 0.23 points.yr -1 Troosters ERJ ml.yr -1 * 53 ml.yr ml.yr points.yr -1 PROs: Insight in effect

Lung function gas exchange Muscle function Cardiovascular function Body composition Symptoms Physical Activity Exercise Tolerance Exacerbations HRQoL Social support Fear Mood Self efficacy Health Beliefs Past behavior PROs: Insight in effect

Lung function gas exchange Muscle function Cardiovascular function Body composition Symptoms Physical Activity Exercise Tolerance HRQoL Social support Fear Mood Self efficacy Health Beliefs Past behavior PROs: Insight in effect More integration of different additive/complementary effects More confounders not directly related to the intervention

PROs: The regulator’s perspective PROs are nowadays essential to support efficacy Patient reported outcomes to support labeling claims: -Very stringent methodology for development -Subject to regulatory approval -Intermediate feedback is possible (qualification process)

Outline What are patient reported outcomes – The researchers perspective – Regulators perspective PRO science: Validating new PRO’s The example of PROactive

PROs: Very strict guidance on development

Clear concept and conceptual model Does the PRO assess something relevant to patients? Items that are understood by patients and reflect their experience With specific attention to Content and Scoring Culturally sensitive translations Focus groups and patient interviews form the basis Literature and experts are supportive

PROs: Very strict guidance on development Identify concepts & develop conceptual framework Create the instrument (items, scales, format, pilot) Assess measurement properties (Redundancy, revise, MCID, training materials) Modify instrument (concept, population, method of administration) PRO PATIENT INPUT IN EVERY STAGE IS VITAL

An example: PROactive capturing PA Proactive WP2D 2011 PROactive aims at developing PROs that capture physical activity Question 1 Do patients consider physical activity or a change thereof relevant/important?

An example: PROactive capturing PA Proactive WP2D 2011

An example: PROactive capturing PA PROactive aims at developing PROs that capture physical activity Question 1 Do patients consider physical activity or a change thereof relevant/important? Question 2 What is physical activity from a patient perspective

An example: PROactive capturing PA Any bodily movement produced by the skeletal muscles that results in energy expenditure Amount and Intensity of physical activity are important to maintain health Physical activity should be considered as a ‘vital sign’ WHAT DOES ‘PHYSICAL ACTIVITY’ MEAN TO PATIENTS? Caspersen Public Health Rep Haskell Circulation 2007 CDC Physical activity plan March 2010

PROs: Very strict guidance on development Individual interv. Country 1 Individual interv. Country 2 Individual interv. Country 3 Transcribed / translated / Analyzed Language used by COPD patients Dimensions relevant to patients with COPD Focus group Country 1 Focus group Country 2 Focus group Country 3 Focus group Country 4 Transcribed / translated / Analyzed Initial Item list Cognitive debriefing Country 1 Cognitive debriefing Country 2 Cognitive debriefing Country 3 Cognitive debriefing Country 4 Cognitive debriefing Country 5 Cognitive debriefing Country … Item list to initial validation (WP4) Valid and acceptable Activity monitor Expert input Report/ Adapt where needed Literature review Expert input

Influencing factors Disease related -Comorbidity -Exacerbations -Severity Influencing factors Disease related -Comorbidity -Exacerbations -Severity Influencing factors External -Climate -Air quality Influencing factors External -Climate -Air quality Consequences Emotional -Feeling sad -Feeling frustrated -Feeling dependent -Embarassement Consequences Emotional -Feeling sad -Feeling frustrated -Feeling dependent -Embarassement Consequences Social -Feeling Isolated -Others helping -Feeling dependent -Others not understanding Consequences Social -Feeling Isolated -Others helping -Feeling dependent -Others not understanding Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Need for adaptation Need for breaks Slow down Help from others Aids Need for adaptation Need for breaks Slow down Help from others Aids Concept Physical Activity Physical inactivity: Patient perspective

Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Need for adaptation Need for breaks Slow down Help from others Aids Need for adaptation Need for breaks Slow down Help from others Aids Concept Physical Activity 24 items Physical inactivity: Patient perspective

Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Amount of activity Walking outdoors Household Chores Leisure activities Dressing Bathing Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Symptoms / difficulty General dyspnea/Fatigue Symptoms with specific activities Difficulties with activities Need for adaptation Need for breaks Slow down Help from others Aids Need for adaptation Need for breaks Slow down Help from others Aids Concept Physical Activity Questionnaires available Questionnairs available Monitors available New dimention Physical inactivity: Patient perspective

Content validity of the items Validity of the items Response options preferably linear Sensitivity to change The validation process

Item generation Generate the concept Focus groups and interviews (initial item pool) Cognitive debriefing (revised initial item pool) Statistical validation Consolidate items that fit with framework Take out redundant items or those with floor/ceiling effect or poor scoring characteristics Verify pre-specified hypothesis Further validation Check for responsiveness / MID Language controls

The validation process; an example CAT 21 Items 21 items capturing the most important aspects of a patient’s COPD health Individual interviews Focus groups 17 Items Administered in 6 countries in 1490 patients 4 items with Floor- Ceiling – Poor Item to total correlation 14 Items 3 items with High inter item correlation (measuring the same thing) 8 Items 6 items Performing poorly on scoring properties Leaving 8 items with minimal bias for age, gender, country Jones Eur Respir J 2009

Content validity of the items Validity of the items Sensitivity to change Response options preferably linear MID with several interventions Version control (languages!) The validation process

Patient perception of improvement may differ between interventions Troosters ERJ 2011

Patient reported outcomes do highlight unique features of the effects of interventions Methodology to develop PROs has been described recently in much detail by regulators PROs have the benefit of integrating several subtle physiologic changes At the expense of having more potential confounders not directly related to the intervention PROactive is a new PRO that aims at capturing the effects of interventions on PA Summary